WO2005067962A3 - Composition comprenant des facteurs de croissance - Google Patents

Composition comprenant des facteurs de croissance Download PDF

Info

Publication number
WO2005067962A3
WO2005067962A3 PCT/EP2005/000429 EP2005000429W WO2005067962A3 WO 2005067962 A3 WO2005067962 A3 WO 2005067962A3 EP 2005000429 W EP2005000429 W EP 2005000429W WO 2005067962 A3 WO2005067962 A3 WO 2005067962A3
Authority
WO
WIPO (PCT)
Prior art keywords
growth factor
growth factors
oligosaccharides
composition derived
milk goat
Prior art date
Application number
PCT/EP2005/000429
Other languages
English (en)
Other versions
WO2005067962A2 (fr
Inventor
Rodriguez Luis Baro
Puerta Julio Boza
Joya Juristo Fonolla
Escobar Emilia Guadix
Lopez Jesus Jimenez
Leon Eduardo Lopez-Huertas
Antonio Martinez-Ferez
Pei Jordi Xaus
Original Assignee
Puleva Biotech Sa
Rodriguez Luis Baro
Puerta Julio Boza
Joya Juristo Fonolla
Escobar Emilia Guadix
Lopez Jesus Jimenez
Leon Eduardo Lopez-Huertas
Antonio Martinez-Ferez
Pei Jordi Xaus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Puleva Biotech Sa, Rodriguez Luis Baro, Puerta Julio Boza, Joya Juristo Fonolla, Escobar Emilia Guadix, Lopez Jesus Jimenez, Leon Eduardo Lopez-Huertas, Antonio Martinez-Ferez, Pei Jordi Xaus filed Critical Puleva Biotech Sa
Publication of WO2005067962A2 publication Critical patent/WO2005067962A2/fr
Publication of WO2005067962A3 publication Critical patent/WO2005067962A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/06—Mixtures of whey with milk products or milk components
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2210/00—Physical treatment of dairy products
    • A23C2210/20—Treatment using membranes, including sterile filtration
    • A23C2210/202—Treatment of milk with a membrane before or after fermentation of the milk, e.g. UF of diafiltration
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

L'invention concerne une composition obtenue à partir du lait de chèvre comprenant des facteurs de croissance. Cette composition est caractérisée en ce que les facteurs de croissance sont présents dans des quantités qui leur permettent d'être physiologiquement actifs et en ce que ces facteurs sont sélectionnés dans une liste qui comprend: le facteur de croissance épidermal (EGF), le facteur de croissance transformant ß 2(TGFß2), le facteur de croissance de type de l'insuline 1 (IGF-1) et la glycoprotéine ancrée CD-14. L'invention concerne aussi un processus pour obtenir des compositions de l'invention, ainsi qu'un produit alimentaire, un supplément diététique ou un supplément alimentaire, et leur utilisation dans la prévention ou le traitement de maladies ainsi que leur utilisation dans des produits cosmétiques.
PCT/EP2005/000429 2004-01-13 2005-01-12 Composition comprenant des facteurs de croissance WO2005067962A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200400053 2004-01-13
ES200400053U ES1056525Y (es) 2004-01-13 2004-01-13 Halador de tres rodillos para redes y aparejos de pesca.

Publications (2)

Publication Number Publication Date
WO2005067962A2 WO2005067962A2 (fr) 2005-07-28
WO2005067962A3 true WO2005067962A3 (fr) 2005-09-22

Family

ID=32050350

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/000429 WO2005067962A2 (fr) 2004-01-13 2005-01-12 Composition comprenant des facteurs de croissance

Country Status (2)

Country Link
ES (1) ES1056525Y (fr)
WO (1) WO2005067962A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104023560A (zh) * 2011-08-29 2014-09-03 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2288337B1 (es) * 2004-12-28 2008-11-16 Marine Hydrotec Co., Ltd. Dispositivo auxiliar de rodillo para la recogida de redes y metodo de recogida de redes que utiliza el mismo.
CN101420966B (zh) 2006-03-10 2013-07-17 纽崔西亚公司 不可消化的糖用于在出生后给予婴儿最佳开始的用途
WO2007114683A1 (fr) 2006-03-30 2007-10-11 N.V. Nutricia Oligosaccharides de lait destinés à stimuler le système immunitaire
EP2044851A1 (fr) * 2007-09-26 2009-04-08 Nestec S.A. Prévention de l'allergie lors d'un sevrage
CA2705014A1 (fr) * 2007-11-08 2009-05-14 Nestec S.A. Maturation de reponses immunes dans les nouveaux nes
EP2060257A1 (fr) 2007-11-08 2009-05-20 Nestec S.A. Prévention et traitement d'infections secondaires à la suite d'une infection virale
GB2468670A (en) * 2009-03-17 2010-09-22 Separation Technologies Invest Processing whey or raw milk
JP4707768B1 (ja) * 2010-10-28 2011-06-22 マリンハイドロテック株式会社 揚網機
EP2455387A1 (fr) * 2010-11-23 2012-05-23 Nestec S.A. Mélange oligosaccharide et produit alimentaire comportant ce mélange, spécialement une formule pour enfants
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
MY180910A (en) 2010-12-31 2020-12-11 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
ES2657744T3 (es) 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
WO2015095650A1 (fr) 2013-12-19 2015-06-25 Puretein Bioscience Llc. Méthodes de traitement d'un animal
PL3212198T3 (pl) * 2014-10-29 2021-08-23 Glycom A/S Syntetyczna kompozycja i sposób promowania gojenia się błony śluzowej
WO2018048305A1 (fr) 2016-09-12 2018-03-15 Rijksuniversiteit Groningen Galacto-oligosaccharides ramifiés prébiotiques (gos)
US20200123184A1 (en) 2017-06-30 2020-04-23 Glycom A/S Purification of oligosaccharides
CN112358538A (zh) * 2020-11-09 2021-02-12 甘肃黑驴王子生物科技有限公司 一种鲜驴奶中表皮生长因子的富集方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
WO2003041512A1 (fr) * 2001-11-12 2003-05-22 Mars, Incorporated Denree alimentaire

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
WO2003041512A1 (fr) * 2001-11-12 2003-05-22 Mars, Incorporated Denree alimentaire

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MARTINEZ-FEREZ ANTONIO ET AL: "Goat milk as a source of complex, lactose-derived oligosaccharides", FASEB JOURNAL, vol. 16, no. 5, 22 March 2002 (2002-03-22), & ANNUAL MEETING OF PROFESSIONAL RESEARCH SCIENTISTS ON EXPERIMENTAL BIOLOGY; NEW ORLEANS, LOUISIANA, USA; APRIL 20-24, 2002, pages A1011, XP008049418, ISSN: 0892-6638 *
SARNEY DOUGLAS B ET AL: "A novel approach to the recovery of biologically active oligosaccharides from milk using a combination of enzymatic treatment and nanofiltration", BIOTECHNOLOGY AND BIOENGINEERING, vol. 69, no. 4, 20 August 2000 (2000-08-20), pages 461 - 467, XP002334929, ISSN: 0006-3592 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104023560A (zh) * 2011-08-29 2014-09-03 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖

Also Published As

Publication number Publication date
WO2005067962A2 (fr) 2005-07-28
ES1056525U (es) 2004-04-01
ES1056525Y (es) 2004-07-16

Similar Documents

Publication Publication Date Title
WO2005067962A3 (fr) Composition comprenant des facteurs de croissance
CN103415281B (zh) 美肌剂
WO2010012408A3 (fr) Microémulsion
KR20210080180A (ko) 금화규 추출물을 포함하는 피부 주름 및 탄력 개선용 조성물
KR20060082015A (ko) 난유래 골 강화 조성물
CN113115884A (zh) 复合肽固体饮料及其制备方法和应用
CN106722999A (zh) 一种胶原肽制备方法、包含其的低糖胶原养颜糕点及制备方法
CN109122900A (zh) 一种香辣味豆皮及其制备方法
KR20130079147A (ko) 발모 촉진 또는 탈모 방지용 조성물
CN109105532A (zh) 一种孜然味豆皮及其制备方法
KR20050080085A (ko) 발효콩 추출물을 이용한 건강 증진 목욕제 및 피부미용제
CN100534446C (zh) 护肤用口服组合物
CN105360297A (zh) 一种酸奶
EP2723197B1 (fr) Boisson lactee a base de lovastatine de pleurote
CN107746773A (zh) 百香果调料酒及其制作方法
KR102532713B1 (ko) 신규한 사카로미세스 세레비시에 균주 및 이의 용도
JP2006137680A (ja) コラーゲン産生促進剤
JP2007031303A (ja) 美白化粧料
CN104397116A (zh) 一种鳄梨保健糕点制备方法
CA3211101A1 (fr) Nouvelle souche et son utilisation
KR20240066085A (ko) 체내 결합조직을 구성하는 콜라겐의 생합성 증진용 조성물
CN109846052A (zh) 大米蛋白氨基酸营养食品制备方法
JP2007254398A (ja) 肌質改善組成物
CN108567707A (zh) 一种自制蔬菜体膜
JP2006327981A (ja) 美肌パック剤生成用組成物およびこれを含む美肌パック剤

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase